SPECT: Clinical Trials

4 trials of SPECT, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 withdrawn. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Recruiting 2, Completed 1, Withdrawn 1
Phase 21Recruiting 1

Follow SPECT: new trials by email Literature Review of SPECT trials Research Report on SPECT

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Bevacizumab, Capecitabine, Cetuximab - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 3RecruitingECOG-ACRIN Cancer Research Group4082024-04-102026-09-24
[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor
SPECT, PET - Parkinson Disease, Essential Tremor
Phase 3CompletedGE Healthcare1522021-12-012025-11-17
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Chest Radiography, Computed Tomography, Fludeoxyglucose F-18 - Buccal Mucosa Squamous Cell Carcinoma, Floor of Mouth Squamous Cell Carcinoma
Phase 2 / Phase 3RecruitingNRG Oncology6862020-09-232026-08-17
68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO)
68Ga-Citrate PET/MRI, 67Ga-Citrate SPECT, Positron Emission Tomography - Fever of Unknown Origin
Phase 3WithdrawnCarina Mari Aparici2019-01-152022-08-22

Conditions studied

Colorectal Neoplasms (1)  ·  Essential Tremor (1)  ·  Fever of Unknown Origin (1)  ·  Mouth Neoplasms (1)  ·  Parkinson Disease (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Carina Mari Aparici (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  GE Healthcare (1)  ·  NRG Oncology (1)

Countries

United States (3)  ·  Canada (1)  ·  France (1)

Top investigators

Carina Mari Aparici, MD (1)  ·  Michael Lidsky (1)  ·  Stephen Y Lai (1)

NIH funding

U10CA180820 (1), U10CA180868 (1)